| Prior information for population pharmacokinetic and pharmacokinetic/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine AHXP Chan Kwong, EAM Calvier, D Fabre, F Gattacceca, S Khier Journal of pharmacokinetics and pharmacodynamics, 1-16, 2020 | 41 | 2020 |
| An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A … AHXP Chan Kwong, C Cassé-Perrot, MC Costes-Salon, E Jouve, ... Journal of clinical psychopharmacology 40 (3), 222-230, 2020 | 12 | 2020 |
| Model-Informed Therapeutic Drug Monitoring of Meropenem in Critically Ill Patients: Improvement of the Predictive Ability of Literature Models with the PRIOR Approach AHXP Chan Kwong, A O’Jeanson, S Khier European Journal of Drug Metabolism and Pharmacokinetics 46 (3), 415-426, 2021 | 9 | 2021 |
| Can We Predict Individual Concentrations of Tacrolimus After Liver Transplantation? Application and Tweaking of a Published Population Pharmacokinetic Model in Clinical Practice. AHXP Chan Kwong, MA Decrocq-Rudler, L Meunier, J Fraisse, ... Therapeutic Drug Monitoring, 2021 | 6 | 2021 |
| Modélisation avec méthode PRIOR pour l'optimisation de la posologie des médicaments, du développement à la pratique clinique A Chan Kwong Aix-Marseille, 2021 | | 2021 |
